Dermatology Diagnostic Devices and Therapeutics Market
According to Intent Market Research, the Dermatology Diagnostic Devices and Therapeutics Market is expected to grow from USD 12.8 billion in 2023 at a CAGR of 7.4% to touch USD 21.2 billion by 2030. The Dermatology Diagnostic Devices and Therapeutics Market is dominated by key players such as Philips Healthcare, Abbott Laboratories, Siemens Healthineers, 3M Health Care, DermTech, Roche Diagnostics, L'Or–al Group, Allergan, Medtronic, Biolight, Ortho Dermatologics, Strata Skin Sciences, Sun Pharmaceutical Industries, Galderma, Bausch Health